ENHANCED VIRAL TRANSDUCTION EFFICIENCY

The present disclosure provides, among other things, a method of engineering genetically modified cells comprising, maintaining the cells in a collection chamber, contacting the cells with a fluid flow of a composition comprising viral or non-viral particles, thereby engineering genetically modified...

Full description

Saved in:
Bibliographic Details
Main Authors FACHIN, Fabio, MOORE, Nathan
Format Patent
LanguageEnglish
Published 10.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides, among other things, a method of engineering genetically modified cells comprising, maintaining the cells in a collection chamber, contacting the cells with a fluid flow of a composition comprising viral or non-viral particles, thereby engineering genetically modified cells. The present disclosure also provides, among other things, a method of engineering genetically modified cells comprising, subjecting the cells to a centrifugal force, contacting the cells with a fluid flow of a composition comprising viral or non-viral particles, thereby engineering genetically modified cells.
Bibliography:Application Number: US202117995211